AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
+12.37%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$1.48M
AUM Growth
+$1.48M
(+9.7%)
Cap. Flow
-$8K
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$8K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Castle Biosciences
CSTL
$696M
| $877K | 59.46% | 33,626 | – | – |
|
|
WHWK
2
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $377K | 25.56% | 26,666 | – | – |
|
3
Synlogic
SYBX
$17M
| $196K | 13.29% | 205,906 | – | – |
|
|
ACGN
4
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $21K | 1.42% | 56,250 | – | – |
|
|
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
| $4K | 0.27% | 375,000 | – | – |
|
|
NBRV
6
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| – | – | -45,849 | Closed | -$8K |
|